The asia pacific cell culture market size is expected to reach USD 14,603.90 million by 2030, according to a new study by Polaris Market Research. The report “Asia Pacific Cell Culture Market Share, Size, Trends, Industry Analysis Report, By Product; By Consumables (Plates, Flasks, Dishes, Vials, Tubes, Bottles, and Others); By Application; By Country; Segment Forecast, 2023 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The region has witnessed significant growth in the market due to increasing investments in life sciences research, the rising demand for biopharmaceuticals, and advancements in healthcare infrastructure. The focus on research and development activities, collaborations, and advanced research facilities equipped with cell culture technologies have driven market growth. The region's increasing prevalence of chronic diseases, aging population, and need for advanced therapeutics have fueled the demand for cell culture products and techniques, particularly in producing biopharmaceuticals like monoclonal antibodies and vaccines.
Improvements in healthcare infrastructure, especially in countries such as China, India, and Japan, have further supported the adoption of cell culture techniques. Investments in healthcare facilities and the expansion of pharmaceutical manufacturing capabilities have created a favorable environment for the growth of the cell culture market. Pharmaceutical companies in the region increasingly rely on cell culture for drug discovery, development, and production.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/asia-pacific-cell-culture-market/request-for-sample
The COVID-19 pandemic had a moderate impact on the cell culture market in the Asia Pacific region. Disruptions caused by lockdowns, travel restrictions, and supply chain challenges affected research activities and biopharmaceutical production. However, there was an increased demand for cell culture-based testing, vaccine development, and antibody production in response to the pandemic. Overall, the market experienced temporary setbacks and opportunities arising from the need for pandemic-related solutions.
Asia Pacific Cell Culture Market Report Highlights
Polaris Market Research has segmented the Asia Pacific cell culture market report based on product, consumables, application, and country:
Asia Pacific Cell Culture, Product Outlook (Revenue - USD Million, 2018 - 2030)
Asia Pacific Cell Culture, Consumables Outlook (Revenue - USD Million, 2018 - 2030)
Asia Pacific Cell Culture, Application Outlook (Revenue - USD Million, 2018 - 2030)
Asia Pacific Cell Culture, Country Outlook (Revenue - USD Million, 2018 - 2030)
Asia Pacific Cell Culture Market Report Scope
Report Attributes |
Details |
Market size value in 2023 |
USD 5,485.80 million |
Revenue forecast in 2030 |
USD 14,603.90 million |
CAGR |
14.2% from 2018 – 2030 |
Base year |
2021 |
Historical data |
2018 – 2021 |
Forecast period |
2018 – 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2030 |
Segments Covered |
By Product, By Consumables, By Application, By Region |
Country scope |
Japan, China, India, South Korea, Australia, New Zealand, Rest of Asia Pacific |
Key Companies |
China, India, Japan, South Korea, Indonesia, Malaysia, Singapore, Taiwan, Thailand, Philippines, Vietnam, Rest of Asia Pacific |
For Specific Research Requirements |